CPhI Europe 2026: How Indian Pharma Companies Should Prepare to Stand Out

CPhI Europe — the annual global pharmaceutical industry trade fair held in Frankfurt — is the most important pharma networking event for Indian API manufacturers, finished dose companies, CMOs, and pharma machinery suppliers. With 45,000+ visitors from 170+ countries, CPhI offers unparalleled EU pharma buyer access. But with 300+ Indian companies participating, differentiation is critical.

Positioning at CPhI Europe: Indian booths compete for attention from the same pool of EU pharma procurement managers. Differentiation requires: a specific technical message (not "we make APIs" but "we are a leading producer of cardiometabolic APIs with 3 CEPs from EDQM and EU GMP from German BfArM"), clear customer references (EU pharma company logos on your booth signal quality endorsement), and technical staff fluent in EU pharmacopoeia, ICH Q11, and EDQM CEP requirements.

Pre-show buyer targeting: CPhI Europe publishes the exhibitor list 3 months before the show. Cross-reference against your target EU pharma buyers. Request meetings through the CPhI Networking Portal (opens 6 weeks before). For API manufacturers: target procurement teams of Teva, Stada, Zentiva, Sandoz, Krka, Polpharma, and other EU generic manufacturers.

Regulatory conversation preparation: EU pharma buyers at CPhI want to discuss: EU GMP certificate status, CEP coverage for key molecules, ICH Q10 pharmaceutical quality system, site audit history, and API supply continuity plan. Prepare fact sheets on each topic — not slide decks.

PHARMEXCIL India Pavilion: PHARMEXCIL organises an India Pavilion at CPhI Europe — the most cost-effective entry point for first-time Indian pharma exhibitors. Apply 6 months in advance.